Skip to content

Clinical trials

Liver Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Country / region: South Korea Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20121
20144
20153
20163
20173
20184
20201
20213
20222
20231
20245
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting8
Terminated6
Unknown status5
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital4
Yonsei University4
89bio, Inc.2
Chuncheon Sacred Heart Hospital2
Samsung Medical Center2
Abbott1
Alnylam Pharmaceuticals1
Asan Medical Center1
AusperBio Therapeutics Inc.1
Blueprint Medicines Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases35
Carcinoma, Hepatocellular7
Non-alcoholic Fatty Liver Disease7
Digestive System Diseases6
Liver Neoplasms5
Fatty Liver4
Digestive System Neoplasms3
Fibrosis3
Hepatitis B3
Hepatitis B, Chronic3

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.